基本信息
浏览量:56
职业迁徙
个人简介
my research has focused on combination immune checkpoint inhibition. While initially being interested in stage IV disease treatment, we have pioneered neoadjuvant checkpoint inhibition in the last years. This therapeutic approach bears the advantage that one can achieve higher response rates, has more tumor material for translational research from homogenous patient populations, that makes it easier to identify baseline biomarkers and mechanisms of resistance.
Our overall goal is to develop personalized therapies, so that we can offer to every melanoma patient a customized therapy within the next years.
Our overall goal is to develop personalized therapies, so that we can offer to every melanoma patient a customized therapy within the next years.
研究兴趣
论文共 598 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCERno. 9 (2024): 1673-1683
Peter Mohr,Paolo Ascierto,Alfredo Addeo,Maria Grazia Vitale,Paola Queirolo,Christian Blank,Jussi Ekström, Joonas Vainio,Vesa Kataja, Sibel Gunes, Mia Engström-Risku, Henriette Thole,
EJC Skin Cancerpp.100254, (2024)
Alexander C. J. van Akkooi,Tina J. Hieken,Rodabe Amaria,Paolo Ascierto,Christian Blank,Mark Faries,Dirk Grunhagen,David Gyorki,Andrew J. Hayes, Anke Kuijpers,Georgina Long,Joshua M. V. Mammen,
ANNALS OF SURGICAL ONCOLOGYno. 1 (2024): S210-S211
引用0浏览0引用
0
0
PIGMENT CELL & MELANOMA RESEARCHno. 1 (2024)
EClinicalMedicine (2024): 102485-102485
INTERNATIONAL JOURNAL OF CANCERno. 10 (2024): 1760-1771
Cancer Immunology, Immunotherapyno. 2 (2024): 1-10
Rik J. Verheijden, Femke H. Burgers, Josephine C. Janssen, Anouk E. Putker, Sophie P.G.R. Veenstra, Geke A.P. Hospers,Maureen J.B. Aarts, Karel W. Hehenkamp, Veerle L.E. Doornebosch, Marthe Verhaert,Franchette W.P.J. van den Berkmortel,Katerina Chatzidionysiou,
European Journal of Cancer (2024): 114172-114172
ECLINICALMEDICINE (2024): 102485-102485
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn